199 related articles for article (PubMed ID: 29541253)
1. Toll-like receptor 9 activation by CpG oligodeoxynucleotide 7909 enhances the radiosensitivity of A549 lung cancer cells via the p53 signaling pathway.
Yuan S; Qiao T; Li X; Zhuang X; Chen W; Chen X; Zhang Q
Oncol Lett; 2018 Apr; 15(4):5271-5279. PubMed ID: 29541253
[TBL] [Abstract][Full Text] [Related]
2. Bacterial DNA delays human eosinophil apoptosis.
Ilmarinen P; Hasala H; Sareila O; Moilanen E; Kankaanranta H
Pulm Pharmacol Ther; 2009 Jun; 22(3):167-76. PubMed ID: 19073274
[TBL] [Abstract][Full Text] [Related]
3. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor.
Yuan S; Qiao T; Chen W
Cancer Biother Radiopharm; 2011 Apr; 26(2):203-8. PubMed ID: 21539452
[TBL] [Abstract][Full Text] [Related]
4. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
[TBL] [Abstract][Full Text] [Related]
5. Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.
Suwarti S; Yamazaki T; Svetlana C; Hanagata N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1234-9. PubMed ID: 23266611
[TBL] [Abstract][Full Text] [Related]
6. Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9.
Fehér K
Curr Protein Pept Sci; 2019; 20(11):1060-1068. PubMed ID: 31470785
[TBL] [Abstract][Full Text] [Related]
7. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
[TBL] [Abstract][Full Text] [Related]
8. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.
Gekeler V; Gimmnich P; Hofmann HP; Grebe C; Römmele M; Leja A; Baudler M; Benimetskaya L; Gonser B; Pieles U; Maier T; Wagner T; Sanders K; Beck JF; Hanauer G; Stein CA
Oligonucleotides; 2006; 16(1):83-93. PubMed ID: 16584297
[TBL] [Abstract][Full Text] [Related]
9. CpG oligodeoxynucleotide induces apoptosis and cell cycle arrest in A20 lymphoma cells via TLR9-mediated pathways.
Qi XF; Zheng L; Kim CS; Lee KJ; Kim DH; Cai DQ; Qin JW; Yu YH; Wu Z; Kim SK
Mol Immunol; 2013 Jul; 54(3-4):327-37. PubMed ID: 23357786
[TBL] [Abstract][Full Text] [Related]
10. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
11. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
12. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
Front Immunol; 2019; 10():179. PubMed ID: 30800129
[TBL] [Abstract][Full Text] [Related]
13. CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of Toll-like receptor 9.
Yan L; Xu G; Qiao T; Chen W; Yuan S; Li X
Cancer Biother Radiopharm; 2013 Sep; 28(7):559-64. PubMed ID: 23705865
[TBL] [Abstract][Full Text] [Related]
14. CpG-oligodeoxynucleotide inhibits Smad-dependent bone morphogenetic protein signaling: effects on myeloma cell apoptosis and in vitro osteoblastogenesis.
Nørgaard NN; Holien T; Jönsson S; Hella H; Espevik T; Sundan A; Standal T
J Immunol; 2010 Sep; 185(6):3131-9. PubMed ID: 20702733
[TBL] [Abstract][Full Text] [Related]
15. Toll-Like Receptor 21 of Chicken and Duck Recognize a Broad Array of Immunostimulatory CpG-oligodeoxynucleotide Sequences.
Chuang YC; Tseng JC; Yang JX; Liu YL; Yeh DW; Lai CY; Yu GY; Hsu LC; Huang CM; Chuang TH
Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33147756
[TBL] [Abstract][Full Text] [Related]
16. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
[TBL] [Abstract][Full Text] [Related]
17. CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Mason KA; Neal R; Hunter N; Ariga H; Ang K; Milas L
Radiother Oncol; 2006 Aug; 80(2):192-8. PubMed ID: 16905212
[TBL] [Abstract][Full Text] [Related]
18. CpG-containing oligodeoxynucleotides act through TLR9 to enhance the NK cell cytokine response to antibody-coated tumor cells.
Roda JM; Parihar R; Carson WE
J Immunol; 2005 Aug; 175(3):1619-27. PubMed ID: 16034101
[TBL] [Abstract][Full Text] [Related]
19. CpG-oligodeoxynucleotides suppress the proliferation of A549 lung adenocarcinoma cells via toll-like receptor 9 signaling and upregulation of Runt-related transcription factor 3 expression.
Barnie PA; Zhang P; Lu P; Chen X; Su Z; Wang S; Xu H
Biomed Rep; 2014 May; 2(3):374-377. PubMed ID: 24748977
[TBL] [Abstract][Full Text] [Related]
20. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage.
Wu HM; Wang J; Zhang B; Fang L; Xu K; Liu RY
Life Sci; 2016 Sep; 161():51-9. PubMed ID: 27476088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]